News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
For invasive breast cancer, researchers identify biomarkers of treatment response
UNC Lineberger researchers report at the San Antonio Breast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2-positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.
Researchers developing model to predict if chemotherapy will work for aggressive breast cancer
In a study presented at the 2016 San Antonio Breast Cancer Symposium, UNC Lineberger researchers led by Katherine Hoadley, PhD, report they developed a model that can predict which triple negative breast cancer patients will respond to chemotherapy.
Brain metastasis persists despite improved targeted treatment for HER2 breast cancer
In a recent study presented at the San Antonio Breast Cancer Symposium, UNC Lineberger researchers and collaborators investigated the incidence of brain metastasis in the period after a series of drugs were approved to treat HER2-positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States in 1998.
Genetic alterations more common in tumors of older patients with metastatic breast cancer
In a preliminary findings presented at the 2016 San Antonio Breast Cancer Symposium, researchers reported that older patients were as likely as younger patients to receive targeted therapy and enroll in therapeutic trials based on their sequencing results.
Thomas named chair of dermatology department
UNC Lineberger member Nancy Thomas, MD, PhD, has been named Chair of the Department of Dermatology, effective Jan. 1.